Hilary Marston, M.D., medical officer and policy adviser for pandemic preparedness at the National Institute of Allergy and Infectious Diseases, said she and her colleagues are “thrilled” about announcements that at least two COVID-19 vaccines so far have been shown to have an efficacy of over 90% in late-stage clinical trials.
“I don’t think any of us could have hoped for those results,” Marston said during a Nov. 18 interview at the AHCJ Journalism Summit on Infectious Disease. “We are … ready to work with the FDA to get the data to them as soon as possible.”
To see more of this story, click here.
